140 related articles for article (PubMed ID: 33849952)
21. The relationship between platelet-to-lymphocyte ratio and pulmonary embolism severity in acute pulmonary embolism.
Telo S; Kuluöztürk M; Deveci F; Kirkil G
Int Angiol; 2019 Feb; 38(1):4-9. PubMed ID: 30618227
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of the neutrophil-to-lymphocyte, monocyte-to-lymphocyte and lymphocyte-to-platelet ratios for the prognosis of COVID-19-associated complications.
Ramos-Peñafiel CO; Santos-González B; Flores-López EN; Galván-Flores F; Hernández-Vázquez L; Santoyo-Sánchez A; Oca-Yemha RM; Bejarano-Rosales M; Rosas-González É; Olarte-Carrillo I; Martínez-Murillo C; Martínez-Tovar A
Gac Med Mex; 2020; 156(5):405-411. PubMed ID: 33372941
[TBL] [Abstract][Full Text] [Related]
23. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil and Platelet to Lymphocyte Ratios in Associating with Blood Glucose Admission Predict the Functional Outcomes of Patients with Primary Brainstem Hemorrhage.
Fan Z; Hao L; Chuanyuan T; Jun Z; Xin H; Sen L; Juan Q; Cao Y; Mu Y
World Neurosurg; 2018 Aug; 116():e100-e107. PubMed ID: 29689388
[TBL] [Abstract][Full Text] [Related]
25. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.
Yao C; Liu X; Tang Z
Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856
[TBL] [Abstract][Full Text] [Related]
26. Higher admission activated partial thromboplastin time, neutrophil-lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with Diabetes: Findings from Two University Hospitals in the U.K.
Iqbal A; Greig M; Arshad MF; Julian TH; Ee Tan S; Elliott J
Diabetes Res Clin Pract; 2021 Aug; 178():108955. PubMed ID: 34273452
[TBL] [Abstract][Full Text] [Related]
27. Clinical and laboratory characteristics of severe and non-severe patients with COVID-19: A retrospective cohort study in China.
Shi S; Nie B; Chen X; Cai Q; Lin C; Zhao G; Zhang X
J Clin Lab Anal; 2021 Jan; 35(1):e23692. PubMed ID: 33389777
[TBL] [Abstract][Full Text] [Related]
28. Neutrophil-to-Lymphocyte Ratio, derived Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio as risk factors in critically ill COVID-19 patients, a single centered study.
Noor A; Akhtar F; Tashfeen S; Anwar N; Saleem B; Khan SA; Akram Z; Shahid S
J Ayub Med Coll Abbottabad; 2020; 32(Suppl 1)(4):S595-S601. PubMed ID: 33754514
[TBL] [Abstract][Full Text] [Related]
29. The role of hemogram parameters and C-reactive protein in predicting mortality in COVID-19 infection.
Acar E; Demir A; Yıldırım B; Kaya MG; Gökçek K
Int J Clin Pract; 2021 Jul; 75(7):e14256. PubMed ID: 33887100
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
[TBL] [Abstract][Full Text] [Related]
31. Predictive ability of admission neutrophil to lymphocyte ratio on short-term outcome in patients with spontaneous cerebellar hemorrhage.
Zhang F; Ren Y; Shi Y; Fu W; Tao C; Li X; Yang M; You C; Xin T
Medicine (Baltimore); 2019 Jun; 98(25):e16120. PubMed ID: 31232961
[TBL] [Abstract][Full Text] [Related]
32. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
Wang Z; Wang Z
BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
[TBL] [Abstract][Full Text] [Related]
33. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19.
Xue G; Gan X; Wu Z; Xie D; Xiong Y; Hua L; Zhou B; Zhou N; Xiang J; Li J
Int Immunopharmacol; 2020 Dec; 89(Pt A):107065. PubMed ID: 33045571
[TBL] [Abstract][Full Text] [Related]
34. Inflammation-associated factors for predicting in-hospital mortality in patients with COVID-19.
Wang JH; Chen RD; Yang HK; Zeng LC; Chen H; Hou YY; Hu W; Yu JS; Li H
J Med Virol; 2021 May; 93(5):2908-2917. PubMed ID: 33393678
[TBL] [Abstract][Full Text] [Related]
35. Derivation and validation of a prognostic model for predicting in-hospital mortality in patients admitted with COVID-19 in Wuhan, China: the PLANS (platelet lymphocyte age neutrophil sex) model.
Li J; Chen Y; Chen S; Wang S; Zhang D; Wang J; Postmus D; Zeng H; Qin G; Shen Y; Jiang J; Yu Y
BMC Infect Dis; 2020 Dec; 20(1):959. PubMed ID: 33334318
[TBL] [Abstract][Full Text] [Related]
36. Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.
Wang X; Li X; Shang Y; Wang J; Zhang X; Su D; Zhao S; Wang Q; Liu L; Li Y; Chen H
Epidemiol Infect; 2020 Sep; 148():e211. PubMed ID: 32900409
[TBL] [Abstract][Full Text] [Related]
37. Poor Survival in COVID-19 Associated with Lymphopenia and Higher Neutrophile-Lymphocyte Ratio.
Montiel-Cervantes LA; Medina G; Pilar Cruz-Domínguez M; Pérez-Tapia SM; Jiménez-Martínez MC; Arrieta-Oliva HI; Carballo-Uicab G; López-Pelcastre L; Camacho-Sandoval R
Isr Med Assoc J; 2021 Mar; 23(3):153-159. PubMed ID: 33734627
[TBL] [Abstract][Full Text] [Related]
38. IL-6-based mortality risk model for hospitalized patients with COVID-19.
Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of static and dynamic biomarkers in COVID-19 patients: a prospective cohort study.
Hormanstorfer M; Borodowski H; Nelson K; Patrosso MJ; Kolland I; Italiano L; Casali VI; Barrios PV; Hernández Sepulveda LF; Tanaro ME; Aldana Petraglia C; Aguzezko AD; Luna C; Mouse C; Gandino I; Presas JL; Paulin F
Rev Esp Quimioter; 2021 Aug; 34(4):308-314. PubMed ID: 34056893
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection.
Maguire D; Woods M; Richards C; Dolan R; Veitch JW; Sim WMJ; Kemmett OEH; Milton DC; Randall SLW; Bui LD; Goldmann N; Cameron A; Laird B; Talwar D; Godber I; Davidson A; McMillan DC
J Transl Med; 2020 Sep; 18(1):354. PubMed ID: 32933530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
